Source link : https://www.newshealth.biz/health-news/fda-approves-ustekinumab-biosimilar-yesintek/
The US Food and Drug Administration (FDA) has approved ustekinumab-kfce (Yesintek) as a biosimilar to ustekinumab (Stelara) for the treatment of Crohn’s disease, ulcerative colitis, plaque psoriasis, and psoriatic arthritis. This is the sixth ustekinumab biosimilar approved by the FDA. The biosimilar was developed by Biocon Biologics, a biosimilars company based in Karnataka, India. Biocon […]
Author : News Health
Publish date : 2024-12-03 05:19:04
Copyright for syndicated content belongs to the linked Source.
Categories